AAAAAA
Results: 1-25/26
Authors:
Lowy, AM
Feig, BW
Janjan, N
Rich, TA
Pisters, PWT
Ajani, JA
Mansfield, PF
Citation: Am. Lowy et al., A pilot study of preoperative chemoradiotherapy for resectable gastric cancer, ANN SURG O, 8(6), 2001, pp. 519-524
Authors:
Ajani, JA
Citation: Ja. Ajani, Introduction - New Approaches in the Management of Breast Cancer - The University of Texas M. D. Anderson Cancer Center Investigators' Workshop, ONCOLOGY-NY, 15(5), 2001, pp. 5-6
Authors:
Ajani, JA
Citation: Ja. Ajani, Irinotecan in gastrointestinal malignancies, ONCOLOGY-NY, 15(3), 2001, pp. 9-10
Authors:
Ajani, JA
Baker, J
Pisters, PW
Ho, LN
Feig, B
Mansfield, PF
Citation: Ja. Ajani et al., Irinotecan plus cisplatin in advanced gastric or gastroesophageal junctioncarcinoma, ONCOLOGY-NY, 15(3), 2001, pp. 52-54
Authors:
Ajani, JA
Citation: Ja. Ajani, Standard chemotherapy for gastric carcinoma: Is it a myth? In reply, J CL ONCOL, 19(10), 2001, pp. 2766-2767
Authors:
Schnirer, II
Komaki, R
Yao, JC
Swisher, S
Putnam, J
Pisters, PWT
Roth, JA
Ajani, JA
Citation: Ii. Schnirer et al., Pilot study of concurrent 5-fluorouracil/paclitaxel plus radiotherapy in patients with carcinoma of the esophagus and gastroesophageal junction, AM J CL ONC, 24(1), 2001, pp. 91-95
Authors:
Pro, B
Lozano, R
Ajani, JA
Citation: B. Pro et al., Therapeutic response to octreotide in patients with refractory CPT-11 induced diarrhea, INV NEW DR, 19(4), 2001, pp. 341-343
Authors:
Macdonald, JS
Smalley, SR
Benedetti, J
Hundahl, SA
Estes, NC
Stemmermann, GN
Haller, DG
Ajani, JA
Gunderson, LL
Jessup, JM
Martenson, JA
Citation: Js. Macdonald et al., Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction., N ENG J MED, 345(10), 2001, pp. 725-730
Authors:
Ajani, JA
Komaki, R
Putnam, JB
Walsh, G
Nesbitt, J
Pisters, PW
Lynch, PM
Vaporciyan, A
Smythe, R
Lahoti, S
Raijman, I
Swisher, S
Martin, FD
Roth, JA
Citation: Ja. Ajani et al., A three-step strategy of induction chemotherapy then chemoradiation followed by surgery in patients with potentially resectable carcinoma of the esophagus or gastroesophageal junction, CANCER, 92(2), 2001, pp. 279-286
Authors:
Ajani, JA
Kelsen, DP
Haller, D
Hargraves, K
Healey, D
Citation: Ja. Ajani et al., A multi-institutional phase II study of BMS-182248-01 (BR96-doxorubicin conjugate) administered every 21 days in patients with advanced gastric adenocarcinoma, CANCER J, 6(2), 2000, pp. 78-81
Authors:
Ajani, JA
Citation: Ja. Ajani, The evolving role of irinotecan: A broad-spectrum chemotherapeutic agent -Introduction, ONCOLOGY-NY, 14(12), 2000, pp. 17-18
Authors:
Ajani, JA
Fairweather, J
Pisters, PW
Charnsangavej, C
Citation: Ja. Ajani et al., Irinotecan and cisplatin in advanced gastric or gastroesophageal junction carcinoma, ONCOLOGY-NY, 14(12), 2000, pp. 19-21
Authors:
Komaki, R
Janjan, NA
Ajani, JA
Lynch, PM
Fairweather, JS
Raijman, I
Blumenshein, GR
Ho, L
Pisters, PWT
Feig, BW
Walsh, GL
Pazdur, R
Citation: R. Komaki et al., Phase I study of irinotecan and concurrent radiation therapy for upper GI tumors, ONCOLOGY-NY, 14(12), 2000, pp. 34-37
Authors:
Ajani, JA
Citation: Ja. Ajani, Standard chemotherapy for gastric carcinoma: Is it a myth?, J CL ONCOL, 18(23), 2000, pp. 4001-4002
Authors:
Yao, JC
Ajani, JA
Citation: Jc. Yao et Ja. Ajani, Gastric cancer, CURR OPIN G, 16(6), 2000, pp. 516-521
Authors:
Swisher, SG
DeFord, L
Merriman, KW
Walsh, GL
Smythe, R
Vaporicyan, A
Ajani, JA
Brown, T
Komaki, R
Roth, JA
Putnam, JB
Citation: Sg. Swisher et al., Effect of operative volume on morbidity, mortality, and hospital use afteresophagectomy for cancer, J THOR SURG, 119(6), 2000, pp. 1126-1132
Authors:
Ajani, JA
Citation: Ja. Ajani, Principles of neoadjuvant therapy - Strategies for preoperative treatment of locoregional cancers - An opportunity for revising existing concepts, CHIRURG, 71(12), 2000, pp. 1431-1432
Authors:
Medgyesy, DC
Wolff, RA
Putnam, JB
Ajani, JA
Citation: Dc. Medgyesy et al., Small cell carcinoma of the esophagus - The University of Texas M, D. Anderson Cancer Center experience and literature review, CANCER, 88(2), 2000, pp. 262-267
Authors:
Ajani, JA
Mansfield, PF
Dumas, P
Citation: Ja. Ajani et al., Oral etoposide for patients with metastatic gastric adenocarcinoma, CA J SCI AM, 5(2), 1999, pp. 112-114
Authors:
York, JE
Stringer, J
Ajani, JA
Wildrick, DM
Gokaslan, ZL
Citation: Je. York et al., Gastric cancer and metastasis to the brain, ANN SURG O, 6(8), 1999, pp. 771-776
Authors:
Kim, YH
Ajani, JA
Carrasco, CH
Dumas, P
Richli, W
Lawrence, D
Chuang, V
Wallace, S
Citation: Yh. Kim et al., Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma, CANCER INV, 17(7), 1999, pp. 474-478
Authors:
Ajani, JA
Mansfield, PF
Lynch, PM
Pisters, PW
Feig, B
Dumas, P
Evans, DB
Raijman, I
Hargraves, K
Curley, S
Ota, DM
Citation: Ja. Ajani et al., Enhanced staging and all chemotherapy preoperatively in patients with potentially resectable gastric carcinoma, J CL ONCOL, 17(8), 1999, pp. 2403-2411
Authors:
Ajani, JA
Takiuchi, H
Citation: Ja. Ajani et H. Takiuchi, Recent developments in oral chemotherapy options for gastric carcinoma, DRUGS, 58, 1999, pp. 85-90
Authors:
Shimada, K
Ajani, JA
Citation: K. Shimada et Ja. Ajani, Adjuvant therapy for gastric carcinoma patients in the past 15 years - A review of western and oriental trials, CANCER, 86(9), 1999, pp. 1657-1668
Authors:
Lowy, AM
Mansfield, PF
Leach, SD
Pazdur, R
Dumas, P
Ajani, JA
Citation: Am. Lowy et al., Response to neoadjuvant chemotherapy best predicts survival after curativeresection of gastric cancer, ANN SURG, 229(3), 1999, pp. 303-308